Organogenesis

Yahoo Finance • 10 days ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 16 days ago

Organogenesis hits setback as second late-stage ReNu study misses key endpoint

[A senior Asian woman massaging her knee, suffering from pain in leg while sitting on sofa in the living room at home] Thai Liang Lim/iStock via Getty Images * Organogenesis (NASDAQ:ORGO [https://seekingalpha.com/symbol/ORGO]) said a se... Full story

Yahoo Finance • 16 days ago

Organogenesis Provides Update on Second Phase 3 ReNu® Study

Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not meeting the primary endpoint Statistica... Full story

Yahoo Finance • last month

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 3 months ago

Biggest stock movers Tuesday: NVDA, TTD, and more

[Man looking at currency trading app on his smart phone from his home office] Alistair Berg Stock futures edged higher early Tuesday as investors awaited the kickoff of earnings season, with major banks JPMorgan (JPM), Citigroup (C), and... Full story

Yahoo Finance • 3 months ago

CMS proposed payment rule aims to cut waste, boost chronic disease management

[Centers For Medicare And Medicaid Services Headquarters] A proposed payment rule unveiled Monday by CMS aims to reduce unnecessary spending and boost quality measures, as well as launch a new payment model centered on chronic disease man... Full story

Yahoo Finance • 4 months ago

Monday 6/9 Insider Buying Report: AMPY, ORGO

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is th... Full story

Yahoo Finance • 6 months ago

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wo... Full story

Yahoo Finance • 6 months ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wo... Full story

Yahoo Finance • 8 months ago

Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025

CANTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 2 years ago

Organogenesis (ORGO) Q3 2023 Earnings Call Transcript

Welcome, ladies and gentlemen, to the third quarter 2023 earnings conference call for Organogenesis Holdings Inc. At this time, all participants have been placed in a listen-only mode. Before we begin, I would like to remind everyone that... Full story

Yahoo Finance • 2 years ago

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

CANTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 2 years ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

CANTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 2 years ago

Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS

CANTON, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wo... Full story

Yahoo Finance • 2 years ago

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

CANTON, Mass. , Sept. 06, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced W... Full story

Yahoo Finance • 2 years ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023

CANTON, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 2 years ago

Bionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth

Alan Fisher appointed Chair of the Board of DirectorsTim Cunningham joins as Chief Financial Officer ADELAIDE, Australia and CAMBRIDGE, Mass., July 03, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or C... Full story

Yahoo Finance • 2 years ago

Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results

CANTON, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Woun... Full story

Yahoo Finance • 2 years ago

Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors

CANTON, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wo... Full story

Yahoo Finance • 3 years ago

Organogenesis Applauds Findings from the Office of Inspector General

CANTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wo... Full story